Efficient Solutions for Researchers in Studying Immune Therapeutics
Therapeutics that block inhibitory checkpoints or activate stimulatory checkpoints have proven to be effective in restoring anti-tumor immune responses and treating cancer in recent years. In particular, the FDA-approved drugs targeting immune checkpoints like cytotoxic T-lymphocyte antige